DD DuPont
A smaller, cleaner DuPont: steady water and Tyvek franchises, fairly priced unless margins truly reach 20%+.
The story
Post-Qnity spin, DuPont is a focused specialty materials company built on water purification (membranes, ion exchange), healthcare and protective materials (Tyvek, medical packaging) and building technologies, with about $6.9B of revenue. It has real moats in brands, specifications and regulatory qualifications, but it is a mature, cyclically exposed business. The reported collapse in revenue and margins mostly reflects divestitures, spin accounting, amortization and impairments, not a broken franchise. Its life cycle is mature, with modest GDP-plus growth and margins that should normalize to specialty-chemical levels.
The 1.8% to 7.5% reported margins carry spin costs, intangible amortization and one-offs. Adjusted EBITDA margins of about 24%, less D&A of roughly 5% of sales, point to a sustainable pre-amortization EBIT margin near 20%, reached over 4 years. I used a 1.1 sales-to-capital ratio because the TTM figure of 0.2 is distorted by acquisition goodwill and partial-period revenue; 1.1 reflects incremental capex intensity in line with peers. Growth of 3-4% fits water and healthcare tailwinds offset by construction cyclicality.
Value drivers
| Revenue growth (Y1) | 3.5% |
| Terminal growth | 3.0% |
| Forecast horizon | 7y |
| Target operating margin | 20.0% |
| Years to target margin | 4 |
| Sales-to-capital | 1.10 |
| Beta | 1.05 |
| Failure probability | 2.0% |
| Cost of capital (WACC) | 9.5% |
| Terminal WACC | 9.3% |
Valuation bridge
| PV of explicit FCFF | 1.37B |
| PV of terminal value | 3.33B |
| Equity value | 2.00B |
| ÷ shares → per share | $15.11 |
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 3.59B | 3.5% | 5.5% | 129.44M | 110.50M | 18.93M | 17.29M |
| 2 | 3.72B | 3.4% | 10.4% | 250.33M | 111.65M | 138.68M | 115.71M |
| 3 | 3.84B | 3.3% | 15.2% | 379.02M | 112.65M | 266.37M | 203.01M |
| 4 | 3.97B | 3.2% | 20.0% | 515.60M | 113.49M | 402.10M | 279.93M |
| 5 | 4.09B | 3.2% | 20.0% | 531.92M | 114.18M | 417.75M | 265.64M |
| 6 | 4.22B | 3.1% | 20.0% | 548.32M | 114.69M | 433.63M | 251.88M |
| 7 | 4.34B | 3.0% | 20.0% | 564.77M | 115.03M | 449.74M | 238.62M |
Key risks
- Residential and non-residential construction downturn hits building technologies volumes
- Margin dilution or stranded costs after the Qnity separation
- PFAS litigation and environmental liabilities from legacy operations
Catalysts
- Water technology demand from desalination, reuse and PFAS remediation regulation
- Portfolio pruning and buybacks lifting returns on capital
⚠ Extreme gap to market price — large, heavily-covered stocks are rarely mispriced this much; the gap likely embeds disruption, decline, or balance-sheet risk the model underweights. Treat as a flag to investigate, not a verdict.